Pharmacokinetics of pipecurium bromide, a new non-depolarizing neuromuscular blocking agent, in humans

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

The pharmacokinetics of 2β,16β-bis-(4'-dimethyl-1'-piperazino)-3α,17β-diacetoxy-5α-androstane dibromide (pipecurium bromide, Arduan®), a new non-depolarizing neuromuscular blocking agent, was studied in surgical patients. Plasma concentration-time curves of pipecurium bromide were evaluated by fitting the data to a bi-exponential equation. The average half-lives were T(α)( 1/2 ) = 4.1±1.4 (n = 8) and T(β)( 1/2 ) = 44±7 (n = 8) min. The pharmacokinetic parameters of pipecurium bromide were found as follows: apparent distribution volume Vβ = 261±28 (n = 8) ml/kg, plasma clearance Cl = 320±55 (n = 8) ml/min. The microconstants of two-compartment open models were also calculated.

Original languageEnglish
Pages (from-to)1754-1756
Number of pages3
JournalArzneimittel-Forschung
Volume31
Issue number10
Publication statusPublished - 1981

Fingerprint

Pipecuronium
Neuromuscular Blocking Agents
Pharmacokinetics
Plasmas

ASJC Scopus subject areas

  • Chemistry(all)
  • Organic Chemistry
  • Drug Discovery
  • Pharmacology

Cite this

Pharmacokinetics of pipecurium bromide, a new non-depolarizing neuromuscular blocking agent, in humans. / Tassonyi, E.; Szabo, G.; Vereczkey, L.

In: Arzneimittel-Forschung, Vol. 31, No. 10, 1981, p. 1754-1756.

Research output: Contribution to journalArticle

@article{f070f40f703247e78b473fc8b89348ec,
title = "Pharmacokinetics of pipecurium bromide, a new non-depolarizing neuromuscular blocking agent, in humans",
abstract = "The pharmacokinetics of 2β,16β-bis-(4'-dimethyl-1'-piperazino)-3α,17β-diacetoxy-5α-androstane dibromide (pipecurium bromide, Arduan{\circledR}), a new non-depolarizing neuromuscular blocking agent, was studied in surgical patients. Plasma concentration-time curves of pipecurium bromide were evaluated by fitting the data to a bi-exponential equation. The average half-lives were T(α)( 1/2 ) = 4.1±1.4 (n = 8) and T(β)( 1/2 ) = 44±7 (n = 8) min. The pharmacokinetic parameters of pipecurium bromide were found as follows: apparent distribution volume Vβ = 261±28 (n = 8) ml/kg, plasma clearance Cl = 320±55 (n = 8) ml/min. The microconstants of two-compartment open models were also calculated.",
author = "E. Tassonyi and G. Szabo and L. Vereczkey",
year = "1981",
language = "English",
volume = "31",
pages = "1754--1756",
journal = "Drug Research",
issn = "2194-9379",
publisher = "Thieme",
number = "10",

}

TY - JOUR

T1 - Pharmacokinetics of pipecurium bromide, a new non-depolarizing neuromuscular blocking agent, in humans

AU - Tassonyi, E.

AU - Szabo, G.

AU - Vereczkey, L.

PY - 1981

Y1 - 1981

N2 - The pharmacokinetics of 2β,16β-bis-(4'-dimethyl-1'-piperazino)-3α,17β-diacetoxy-5α-androstane dibromide (pipecurium bromide, Arduan®), a new non-depolarizing neuromuscular blocking agent, was studied in surgical patients. Plasma concentration-time curves of pipecurium bromide were evaluated by fitting the data to a bi-exponential equation. The average half-lives were T(α)( 1/2 ) = 4.1±1.4 (n = 8) and T(β)( 1/2 ) = 44±7 (n = 8) min. The pharmacokinetic parameters of pipecurium bromide were found as follows: apparent distribution volume Vβ = 261±28 (n = 8) ml/kg, plasma clearance Cl = 320±55 (n = 8) ml/min. The microconstants of two-compartment open models were also calculated.

AB - The pharmacokinetics of 2β,16β-bis-(4'-dimethyl-1'-piperazino)-3α,17β-diacetoxy-5α-androstane dibromide (pipecurium bromide, Arduan®), a new non-depolarizing neuromuscular blocking agent, was studied in surgical patients. Plasma concentration-time curves of pipecurium bromide were evaluated by fitting the data to a bi-exponential equation. The average half-lives were T(α)( 1/2 ) = 4.1±1.4 (n = 8) and T(β)( 1/2 ) = 44±7 (n = 8) min. The pharmacokinetic parameters of pipecurium bromide were found as follows: apparent distribution volume Vβ = 261±28 (n = 8) ml/kg, plasma clearance Cl = 320±55 (n = 8) ml/min. The microconstants of two-compartment open models were also calculated.

UR - http://www.scopus.com/inward/record.url?scp=0019465854&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0019465854&partnerID=8YFLogxK

M3 - Article

C2 - 6274362

AN - SCOPUS:0019465854

VL - 31

SP - 1754

EP - 1756

JO - Drug Research

JF - Drug Research

SN - 2194-9379

IS - 10

ER -